Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P; CORONA Study Group.
Gullestad L, et al.
Eur Heart J. 2012 Sep;33(18):2290-6. doi: 10.1093/eurheartj/ehs077. Epub 2012 Apr 17.
Eur Heart J. 2012.
PMID: 22513778
Clinical Trial.